David Piacquad Amgen Inc (AMGN) insider trading activity

David Piacquad is SVP, Business Development of AMGEN INC. Currently has a direct ownership of 44,787 shares of AMGN, which is worth approximately $14.3 Million. The most recent transaction as insider was on May 11, 2018, when has been sold 9,860 shares (Common Stock) at a price of $170.77 per share, resulting in proceeds of $1,683,792. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.8K

0% 3M change

0% 12M change

Total Value Held $14.3 Million

David Piacquad Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 11 2018	SELL Payment of exercise price or tax liability	$1,683,792 $170.77 p/Share	9,860 Reduced 19.12%	41,706 Common Stock
May 11 2018	BUY Exercise of conversion of derivative security	$820,650 $54.71 p/Share	15,000 Added 22.53%	51,566 Common Stock
May 03 2018	SELL Payment of exercise price or tax liability	$30,159 $169.43 p/Share	178 Reduced 0.48%	36,566 Common Stock
Apr 27 2018	BUY Grant, award, or other acquisition	-	957 Added 2.54%	36,744 Common Stock
Apr 25 2018	SELL Payment of exercise price or tax liability	$37,311 $171.94 p/Share	217 Reduced 0.6%	35,787 Common Stock
Mar 23 2018	SELL Payment of exercise price or tax liability	$267,466 $176.08 p/Share	1,519 Reduced 4.05%	36,004 Common Stock
Mar 07 2018	BUY Grant, award, or other acquisition	-	4,031 Added 9.71%	37,474 Common Stock
Jan 30 2018	SELL Payment of exercise price or tax liability	$30,294 $198.0 p/Share	153 Reduced 0.46%	33,443 Common Stock
May 01 2017	BUY Grant, award, or other acquisition	-	984 Added 2.85%	33,533 Common Stock
Apr 26 2017	SELL Payment of exercise price or tax liability	$458,360 $164.7 p/Share	2,783 Reduced 7.88%	32,549 Common Stock
Apr 25 2017	SELL Payment of exercise price or tax liability	$35,075 $163.14 p/Share	215 Reduced 0.6%	35,332 Common Stock
Mar 24 2017	SELL Payment of exercise price or tax liability	$419,749 $166.04 p/Share	2,528 Reduced 6.64%	35,547 Common Stock
Mar 07 2017	BUY Grant, award, or other acquisition	-	5,635 Added 12.92%	37,989 Common Stock
Jan 30 2017	SELL Payment of exercise price or tax liability	$25,146 $157.16 p/Share	160 Reduced 0.49%	32,354 Common Stock
May 03 2016	BUY Grant, award, or other acquisition	-	1,023 Added 3.06%	32,359 Common Stock
Apr 27 2016	SELL Payment of exercise price or tax liability	$47,064 $162.85 p/Share	289 Reduced 0.91%	31,336 Common Stock
Apr 26 2016	SELL Payment of exercise price or tax liability	$25,173 $163.46 p/Share	154 Reduced 0.48%	31,635 Common Stock
Apr 25 2016	SELL Payment of exercise price or tax liability	$34,270 $163.19 p/Share	210 Reduced 0.66%	31,789 Common Stock
Mar 25 2016	SELL Payment of exercise price or tax liability	$344,297 $149.24 p/Share	2,307 Reduced 6.72%	31,999 Common Stock
Mar 02 2016	BUY Grant, award, or other acquisition	-	5,305 Added 13.42%	34,212 Common Stock
Apr 27 2015	SELL Payment of exercise price or tax liability	$46,007 $167.91 p/Share	274 Reduced 0.94%	28,784 Common Stock
Apr 26 2015	SELL Payment of exercise price or tax liability	$444,626 $167.91 p/Share	2,648 Reduced 8.35%	29,058 Common Stock
Apr 25 2015	SELL Payment of exercise price or tax liability	$55,410 $167.91 p/Share	330 Reduced 1.03%	31,706 Common Stock
Mar 27 2015	SELL Payment of exercise price or tax liability	$706,741 $160.55 p/Share	4,402 Reduced 12.08%	32,036 Common Stock
Mar 04 2015	BUY Grant, award, or other acquisition	-	9,459 Added 20.66%	36,321 Common Stock

Also insider at

NMRA

Neumora Therapeutics, Inc.

David Piacquad

SVP, Business Development

Thousand Oaks, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMGN shares.

Notify only if

Value

Insider Trading

Get notified when an Amgen Inc insider buys or sells AMGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMGEN INC

Track Activities on AMGN

Account